908 Devices Inc (MASS)
5.56
-0.06
(-1.07%)
USD |
NASDAQ |
Apr 25, 16:00
5.55
-0.01
(-0.18%)
After-Hours: 20:00
908 Devices SG&A Expense (Quarterly): 11.54M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 11.54M |
September 30, 2023 | 11.42M |
June 30, 2023 | 11.21M |
March 31, 2023 | 12.00M |
December 31, 2022 | 11.60M |
September 30, 2022 | 11.83M |
June 30, 2022 | 10.71M |
March 31, 2022 | 9.745M |
December 31, 2021 | 8.917M |
Date | Value |
---|---|
September 30, 2021 | 8.786M |
June 30, 2021 | 8.779M |
March 31, 2021 | 5.753M |
December 31, 2020 | 4.183M |
September 30, 2020 | 3.178M |
June 30, 2020 | 2.436M |
March 31, 2020 | 2.706M |
December 31, 2019 | 2.67M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
2.436M
Minimum
Jun 2020
12.00M
Maximum
Mar 2023
8.086M
Average
8.917M
Median
Dec 2021
SG&A Expense (Quarterly) Benchmarks
Perspective Therapeutics Inc | 1.694M |
Retractable Technologies Inc | 4.158M |
Xtant Medical Holdings Inc | 20.45M |
Asensus Surgical Inc | 7.773M |
Catheter Precision Inc | 2.729M |